PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22400806-8	2012	Enzyme-linked immunosorbent assay results indicated that Lico A can significantly down-regulate TNF-alpha, IL-6, and IL-1beta levels in vitro and in vivo, and treatment with Lico A significantly attenuated alveolar wall thickening, alveolar hemorrhage, interstitial edema, and inflammatory cells infiltration in mice with ALI.	licochalcone A	57-63	interleukin 1 beta	Mus musculus	117-125	
22400806-8	2012	Enzyme-linked immunosorbent assay results indicated that Lico A can significantly down-regulate TNF-alpha, IL-6, and IL-1beta levels in vitro and in vivo, and treatment with Lico A significantly attenuated alveolar wall thickening, alveolar hemorrhage, interstitial edema, and inflammatory cells infiltration in mice with ALI.	licochalcone A	174-180	interleukin 1 beta	Mus musculus	117-125	
32965793-6	2020	In vitro, Lico A could reduce the expression of NLRP3, apoptosis-associated speck-like protein (ASC), Gasdermin D (GSDMD), caspase-1, interleukin-1beta (IL-1beta) and IL-18, which indicated that Lico A attenuates LPS-induced chondrocytes pyroptosis.	licochalcone A	10-16	interleukin 1 beta	Mus musculus	134-151	
26552405-8	2016	Lico A also suppressed LPS-induced TNF-alpha, IL-6, and IL-1beta production both in serum and kidney tissues.	licochalcone A	0-6	interleukin 1 beta	Mus musculus	56-64